Potential for jaktinib hydrochloride to treat cytokine storms in patients with COVID-19
Item
Click for External Resource*
Click to read full article*
*The link above may share a zip file (.zip) hosted on repository.netecweb.org. Zip files will download automatically.
*All other links are external and will open in a new window. If you click an external link, you are leaving the NETEC site, and we do not maintain, review, or endorse these materials. See our terms of use.
Item Type
PublicationTerms of Use
By accessing these materials you are agreeing to our terms of use, which may be found here: Terms of Use.
Example only: NETEC provides this item for reference purposes but does not endorse its content. Newer versions may be in place at the providing institution.
Title
Potential for jaktinib hydrochloride to treat cytokine storms in patients with COVID-19
Subject
Description
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has become a serious public health threat to the whole world, and the number of infected is still rising dramatically at this moment. Several studies have confirmed that cytokine storms play a critical role in causing a case to worsen from mild to severe or critical.
Date
2020-06-11
Type
Citation
Meng, Xianmin, Yun Ling, Li Zhang, Qian Zhang, Ping Dong, Tongyu Zhu, and Hongzhou Lu. 2020. "Potential for jaktinib hydrochloride to treat cytokine storms in patients with COVID-19." BioScience Trends advpub.
Accessibility
Free access online publication
Was this resource helpful?